NEXVIAZYME is indicated for the treatment of patients 1 year of age and older with late-onset Pompe disease

MAKE THE NEX MOVE FOR
YOUR PATIENTS WITH LOPD

NEXVIAZYME is a monotherapy* for your patients with LOPD who are newly diagnosed or on another ERT1

*Not including premedication or pretreatment. Learn more
The quickstart program image

The QuickStart Program

Transitioning your eligible patients to NEXVIAZYME
can be a seamless process.

Contact a Local Representative

Do you have questions about how to initiate or transition your patient with LOPD to NEXVIAZYME?

Please reach out to your area business manager at any time
or call 1-800-745-44471-800-745-4447, option 5 to be connected with one.